Description of theme 1
Description of theme 2
Description of theme 3
   
 

Department of Medical Oncology
P.O. Box 9101
6500 HB Nijmegen
The Netherlands
T: +31 24 3613457
F: +31 24 3540788

Kees Punt is professor of Immunotherapy of Cancer at the Radboud University Nijmegen Medical Centre. He is vice-chairperson of the department of Medical Oncology.
Prof. dr. C.J.A. Punt

His research interests include experimental immunotherapy of cancer, and in particular the development of dendritic cell vaccines for cancer patients and particularly for melanoma, and gastrointestinal cancer. He is currently the chairperson of the Dutch Colorectal Cancer Group (DCCG), which initiates and coordinates clinical studies in patients with colorectal cancer.

 
Recent key publications

Punt CJA, Nagy A, Douillard JY, Figer A, Skovsgaard T, Monson J, Barone C, Fountzilas G, Riess H, Moylan E, Jones D, Dethling J, Colman J, Coward L, MacGregor S. Edrecolomab(17-1A Antibody) Alone or in Combination with 5-Fluorouracil and Leucovorin in the Adjuvant Treatment of Stage III Colon Cancer: Results of a Multinational Phase III Study. The Lancet 2002;360:671-7.

Punt CJA, Keizer HJ, Douma J, Skovsgaard T, Schuller J, Muller EW, Ten Napet CHH, Croels JJ, Lochs H, Zhang J, Hammershaimb L. Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study. Ann Oncol 2002;13:81-6.

de Vries IJM, Krooshoop DJEB, Scharenborg NM, Lesterhuis WJ, Diepstra JHS, van Muijen GNP, Strijk SP, Ruers TJ, Boerman OC, Oyen WJG, Adema GJ, Punt CJA, Figdor CG. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 2003;63:12-7.

De Vries IJM, Lesterhuis WJ, Scharenborg NM, Engelen LPH, Ruiter DJ, Gerritsen MJP, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJA. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.Clin Cancer Res 2003;9:5091-5100.